Videos

Osman Ahmed, MD, University of Chicago Medicine

Videos

Histotripsy: Current and Future Applications

05/09/2024

Featuring Osman Ahmed, MD

Osman Ahmed, MD, gives an overview of histotripsy and explains the recent #HOPE4LIVER trial, looking the safety and efficacy of this technique for liver tumors.

Osman Ahmed, MD, gives an...

05/09/2024

IO Learning

Christos Georgiades, MD, PhD, Johns Hopkins Hospital

Videos

Physics of Histotripsy

05/09/2024

Featuring Christos Georgiades, MD, PhD

Featuring Christos Georgiades, MD, Ph...

Christos Georgiades, MD, PhD, explains the physics of histotripsy and how this technique differs from existing interventional oncology treatments.

Christos Georgiades, MD, PhD,...

05/09/2024

IO Learning

Videos

Management Considerations for Oral Toxicities Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma

05/09/2024

Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.

Samantha Shenoy, NP, discusses...

05/09/2024

APP Institute Oncology

Seth Wander, MD, PhD, Massachusetts General Hospital

Videos

Novel Endocrine Agents for Patients With HR-Positive Breast Cancer

05/08/2024

Featuring Seth Wander, MD, PhD

Featuring Seth Wander, MD, PhD ...

At Great Debates and Updates in Women’s Oncology, Seth Wander, MD, PhD, discussed whether novel endocrine agents add anything different from SERDs to treatments for patients with hormone receptor-positive metastatic breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Videos

The Case for Platinum-Based Chemotherapy for Patients With Platinum-Sensitive Recurrent Ovarian Cancer

05/08/2024

Featuring Ying Liu, MD, MPH

At the 2024 Great Debates and Updates in Women’s Oncology meeting, Ying Liu, MD, MPH, makes an argument for platinum-based chemotherapy as the optimal treatment for patients with platinum-sensitive recurrent ovarian cancer.

At the 2024 Great Debates and...

05/08/2024

Oncology

Denise Yardley, MD, Sarah Cannon Research Institute

Videos

Is Age 50 Relevant for Decisions in Early HR-Positive Breast Cancer?

05/08/2024

Featuring Denise Yardley, MD

At Great Debates and Updates in Women’s Oncology, Denise Yardley, MD, discusses whether age 50 is relevant for treatment decisions for patients with early HR-positive breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Sarah Smith, Virginia Cancer Specialists

Videos

Post-Progression and Safety Outcomes With First-Line Amivantamab Plus Lazertinib vs Osimertinib for Advanced NSCLC: Best Management Practices

05/08/2024

Sarah Smith, BD, CNMT, discusses findings from the phase 3 MARIPOSA study exploring post-progression and safety outcomes with first-line amivantamab plus lazertinib vs osimertinib for advanced NSCLC and offers guidance for best management...

Sarah Smith, BD, CNMT, discusses...

05/08/2024

APP Institute Oncology

Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center

Videos

Sequential Antibody Drug Conjugates for Patients With Metastatic Breast Cancer

05/08/2024

Featuring Neil Iyengar, MD

At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Videos

Advances in High-Risk Cutaneous Squamous Cell Carcinoma

05/07/2024

Featuring Dr Vishal A. Patel, MD, FAAD, FACMS

Featuring Dr Vishal A. Patel, MD, FAA...

In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.

In this interview, Dr Vishal...

05/07/2024

The Dermatologist